Which immunotherapy companies will be around in 2028?
Basic
8
Ṁ1592028
1D
1W
1M
ALL
62%
Wyndly
60%
Curex
59%
Nectar
I'm trying to pick a provider for at-home sublingual immunotherapy (SLIT), but it takes up to four years to finish and I'm worrying about a startup going out of business or being acquired and no longer offering immunotherapy.
Curex:
founded 2020
can't find funding info
Wyndly:
founded 2020
2mil funding in 2023
yc W21 company
Nectar:
founded 2021
24mil total raised, series a
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will a publicly listed pharma company reach $1T in market cap before 2025?
5% chance
Can we cure at least one autoimmune disease in humans by 2028?
46% chance
Will Immunovant agree to be acquired by the end of 2024?
17% chance
If I get immunotherapy from a startup, will it turn out to be a good idea?
Of the companies which are currently #11-20 in market cap, will any be larger than Eli Lilly (#10) at the end of 2024?
81% chance
Will I get exosome infusions in 2024?
37% chance
Which biotech scaleup will have the largest market cap in 2030?
Which of these protein targets will have at least one new drug targeting them receive FDA approval between 2025 and 2030
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will we get a cure for cancer before 2038?
36% chance